Effects of insulin and maternal diabetes on fetal lipogenesis in the rat

Enzyme
|January 1, 1983
PubMed

Insights

Offspring from diabetic mothers show altered fat production in liver and brown fat. Researchers found differences in how these tissues respond to insulin during development.

Area of Science:

  • Perinatal biology
  • Endocrinology
  • Metabolic research

Background:

  • Maternal diabetes impacts fetal development.
  • Lipogenesis (fat production) is crucial during fetal development.
  • Existing theories do not fully explain these impacts.

Purpose of the Study:

  • Investigate fetal lipogenesis in offspring of diabetic rats.
  • Re-evaluate the effect of exogenous insulin on perinatal lipogenesis.
  • Identify differences in hormone sensitivity between fetal liver and brown adipose tissue.

Main Methods:

  • Studied lipogenesis in fetal hepatic and brown adipose tissues of rat offspring.
  • Utilized offspring from both subdiabetic and overtly diabetic mothers.
  • Examined responses to exogenous insulin.

Main Results:

  • Observed lipogenesis patterns not explained by current theories.
  • Found significant differences in insulin sensitivity between liver and brown adipose tissue.
  • Data obtained from offspring of mothers with varying diabetic states.

Conclusions:

  • Maternal diabetes profoundly affects fetal tissue lipogenesis.
  • Fetal liver and brown adipose tissue exhibit distinct insulin sensitivities.
  • Further research is needed to understand the mechanisms underlying these differences.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.